Literature DB >> 30212867

A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.

Daniel N Johnson1, Allison B Cavallo2, Imran Uraizee1, Kevin Tanager1, Ricardo R Lastra1,3,4, Tatjana Antic1,3,4, Nicole A Cipriani1,4.   

Abstract

Objectives: Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) includes sparsely cellular specimens with nuclear atypia (3N) and/or architectural atypia (3A). This study investigates whether the two types of atypia have different rates of malignancy (ROMs).
Methods: Cytologic and histologic diagnoses of resected thyroid nodules were recorded. ROM was calculated for all Bethesda categories and for 3N and 3A subcategories. Possible noninvasive follicular thyroid neoplasms with papillary-like nuclear features were reviewed and removed from malignancies, and ROM was recalculated.
Results: A total of 1,396 nodules were included. ROM of 3N (33.3%-26.0%) was higher than 3A (7.7%-5.0%) (P < .0001) and was similar to suspicious for follicular neoplasm (25.0%-20.3%) (P = .3). ROM of 3A approached benign (2.4%-1.5%) (P = .02). Conclusions: Strong consideration should be given to separating 3N (nuclear atypia with higher risk for papillary thyroid carcinoma) from 3A (architectural atypia with higher chance of being benign) to convey different ROMs.

Entities:  

Mesh:

Year:  2019        PMID: 30212867     DOI: 10.1093/ajcp/aqy109

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis.

Authors:  Maryam Shahi; Stephen J Bloechl; Rachel I Vogel; Rupendra Shrestha; Hannah R Krigman; Maria Evasovich; Lynn A Burmeister; Khalid Amin
Journal:  Hum Pathol       Date:  2019-08-19       Impact factor: 3.466

2.  Is Subdivision of Atypia of Undetermined Significance AUS/Follicular Lesion of Undetermined Significance Cases According to Detailed Nuclear Features Vital for Assessing the Risk of Malignancy?

Authors:  Esin Kaymaz; Banu Dogan Gun; Ilhan Tasdoven; Furuzan Kokturk
Journal:  J Cytol       Date:  2020-11-06       Impact factor: 1.000

3.  Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates.

Authors:  Samira M Sadowski; Volodymyr Petrenko; Patrick Meyer; Marc Pusztaszeri; Marie-Claude Brulhart-Meynet; Mounia Heddad Masson; Frédéric Triponez; Jacques Philippe; Charna Dibner
Journal:  Gland Surg       Date:  2019-08

4.  A Large Thyroid Fine Needle Aspiration Biopsy Cohort with Long-Term Population-Based Follow-Up.

Authors:  Dianna L Ng; Annemieke van Zante; Ann Griffin; Nancy K Hills; Britt-Marie Ljung
Journal:  Thyroid       Date:  2021-01-29       Impact factor: 6.506

Review 5.  Thyroid cytopathology: updates and molecular testing.

Authors:  J Vance; S M Gilani
Journal:  Pathologica       Date:  2019-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.